Literature DB >> 8985190

Transmission of swine influenza virus to humans after exposure to experimentally infected pigs.

D E Wentworth1, M W McGregor, M D Macklin, V Neumann, V S Hinshaw.   

Abstract

Two people developed symptoms of influenza 36 h after collecting nasal swabs from pigs experimentally infected with A/Sw/IN/1726/88 (Sw/IN). Pharyngeal swabs from these persons tested positive for influenza virus RNA 8 days after infection. Analysis of hemi-nested polymerase chain reaction (PCR) products indicated that the hemagglutinin (HA) segments of the isolates were genetically related to the HA of Sw/IN. Four influenza A virus isolates (A/WI/4754/94, A/WI/4756/94, A/WI/4758/94, A/WI/4760/94) were recovered from a 39-year-old man and 2 (A/WI/4755/94, A/WI/4757/94) from a 31-year-old woman. The HAs of the isolates were antigenically indistinguishable from the virus used to infect the pigs. Sequence analysis of the HA genes indicated they were 99.7% identical to the HA of the virus used in the experiment. Multisegment reverse transcription-PCR proved that all of the segments originated from Sw/IN, demonstrating that transmission of swine H1N1 viruses to humans occurs directly and readily, despite Animal Biosafety Level 3 containment practices used for these experiments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985190     DOI: 10.1093/infdis/175.1.7

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Sporadic human cases of swine-origin influenza before 2009 share the Sa epitope.

Authors:  Sebastian Maurer-Stroh; Swe Swe Thet Paing; Raphael Tze Chuen Lee; Frank Eisenhaber
Journal:  Cell Cycle       Date:  2010-09-26       Impact factor: 4.534

2.  Systematic Review of Important Viral Diseases in Africa in Light of the 'One Health' Concept.

Authors:  Ravendra P Chauhan; Zelalem G Dessie; Ayman Noreddin; Mohamed E El Zowalaty
Journal:  Pathogens       Date:  2020-04-20

3.  Evolution of swine H3N2 influenza viruses in the United States.

Authors:  R J Webby; S L Swenson; S L Krauss; P J Gerrish; S M Goyal; R G Webster
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Isolation and characterization of H4N6 avian influenza viruses from pigs with pneumonia in Canada.

Authors:  A I Karasin; I H Brown; S Carman; C W Olsen
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus.

Authors:  M D Macklin; D McCabe; M W McGregor; V Neumann; T Meyer; R Callan; V S Hinshaw; W F Swain
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs.

Authors:  Aleksandar Masic; Jayaum S Booth; George K Mutwiri; Lorne A Babiuk; Yan Zhou
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

7.  Epidemiological update on swine influenza (H1N1) in pigs.

Authors:  Shiv Chandra Dubey; G Venkatesh; Diwakar D Kulkarni
Journal:  Indian J Microbiol       Date:  2010-01-07       Impact factor: 2.461

Review 8.  Cases of swine influenza in humans: a review of the literature.

Authors:  Kendall P Myers; Christopher W Olsen; Gregory C Gray
Journal:  Clin Infect Dis       Date:  2007-03-06       Impact factor: 9.079

9.  Infection due to 3 avian influenza subtypes in United States veterinarians.

Authors:  Kendall P Myers; Sharon F Setterquist; Ana W Capuano; Gregory C Gray
Journal:  Clin Infect Dis       Date:  2007-05-24       Impact factor: 9.079

10.  Human case of swine influenza A (H1N1) triple reassortant virus infection, Wisconsin.

Authors:  Alexandra P Newman; Erik Reisdorf; Jeanne Beinemann; Timothy M Uyeki; Amanda Balish; Bo Shu; Stephen Lindstrom; Jenna Achenbach; Catherine Smith; Jeffrey P Davis
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.